TSTickerStarGet alerts

Aethlon Medical 8-K: Authorized common shares increased from 20,000,000 to 200,000,000

Aethlon Medical filed an 8-K reporting that, following stockholder approval at the 2026 Annual Meeting on October 1, 2026, an amendment to the Company's Articles of Incorporation increasing authorized common stock from 20,000,000 to 200,000,000 shares became effective on October 7, 2026. The Certificate of Amendment (Exhibit 3.1) was filed with the Nevada Secretary of State on October 8, 2026. The filing does not disclose any issuance of shares, a planned financing, or financial results.

Share this story

Key takeaways

  • Authorized shares: Aethlon's Articles of Incorporation were amended to increase authorized common stock (par value $0.001 per share) from 20,000,000 shares to 200,000,000 shares, a ten-fold increase.

  • Approval and effectiveness: Stockholders approved the Articles Amendment at the 2026 Annual Meeting on October 1, 2026; the amendment became effective upon filing with the Nevada Secretary of State on October 7, 2026.

  • Voting result: Exhibit 3.1 indicates stockholders holding 92% of the voting power approved the amendment.

  • Dilution implications: The increase materially expands the pool of shares available for issuance, which could affect future equity raises, financings, M&A consideration, or stock-based compensation.

  • No financial results: The 8-K does not include earnings, revenue, EPS, or cash flow data; no forward guidance is provided.

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow AEMD in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert